(Q51369555)

English

Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.

scientific article published on 6 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

Michael von Wolff

14

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

author name string

K Behringer

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

I Thielen

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

H Mueller

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

H Goergen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

A D Eibl

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

J Rosenbrock

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

T Halbsguth

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

D A Eichenauer

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

M Fuchs

9

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

K S Reiners

10

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

J H Renno

11

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

K van der Ven

12

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

M Kuehr

13

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

V Diehl

15

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

A Engert

16

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

P Borchmann

17

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

publication date

6 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

23

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

1818-1825

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Fertility preservation after chemotherapy for Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Fertility preservation in adolescents and young adults with cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Treatment-related risk factors for premature menopause following Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

The Menopause Rating Scale (MRS) scale: a methodological review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Reliability of follicle-stimulating hormone measurements in serum

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Anti-Müllerian hormone and its role in ovarian function

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Regulation of ovarian function: the role of anti-Müllerian hormone

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Failure to preserve fertility in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin's lymphoma patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR575

21 January 2018

Identifiers

10.1093/ANNONC/MDR575

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22228451

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51369555&oldid=1520988471"